Cargando…

CD160 receptor in CLL: Current state and future avenues

CD160 is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein expressed on cytotoxic natural killer (NK) cells and T-cell subsets. It plays a crucial role in the activation of NK-cell cytotoxicity and cytokine production. It also modulates the immune system and is involved in some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oumeslakht, Loubna, Aziz, Abdel-ilah, Bensussan, Armand, Ben Mkaddem, Sanae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676924/ https://www.ncbi.nlm.nih.gov/pubmed/36420268 http://dx.doi.org/10.3389/fimmu.2022.1028013

Ejemplares similares

Fc receptors act as innate immune receptors during infection?
por: Laassili, Chaimaa, et al.
Publicado: (2023)

Mechanisms Underlying Potential Therapeutic Approaches for COVID-19
por: Benani, Abdelouaheb, et al.
Publicado: (2020)

Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
por: Ben Mkaddem, Sanae, et al.
Publicado: (2019)

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma
por: Gauci, Marie-Léa, et al.
Publicado: (2022)

HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage
por: Muscate, Franziska, et al.
Publicado: (2018)

High Levels of CD244 Rather Than CD160 Associate With CD8(+) T-Cell Aging
por: Wang, Xinyue, et al.
Publicado: (2022)

Regulatory T-Cells in Pregnancy: Historical Perspective, State of the Art, and Burning Questions
por: Ruocco, Maria Grazia, et al.
Publicado: (2014)

Editorial: The Immunology of Sepsis—Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment
por: Schlapbach, Luregn J., et al.
Publicado: (2020)

Genetic Testing for Inherited Cardiac Arrhythmias: Current State-of-the-Art and Future Avenues
por: Hylind, Robyn J., et al.
Publicado: (2018)

Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
por: Slika, Hasan, et al.
Publicado: (2023)

Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities
por: Redelinghuys, Mathys J., et al.
Publicado: (2020)

Targeting Bruton’s Tyrosine Kinase in CLL
por: Ahn, Inhye E., et al.
Publicado: (2021)

Spatial organization and early signaling of the B-cell receptor in CLL
por: Shorer Arbel, Yamit, et al.
Publicado: (2022)

CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells
por: Zhang, Linxia, et al.
Publicado: (2020)

Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2021)

CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression
por: Sun, Zheng, et al.
Publicado: (2022)

Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
por: Schmitt, Christian, et al.
Publicado: (2017)

Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
por: Shevchenko, Ivan, et al.
Publicado: (2018)

Swine enteric colibacillosis: Current treatment avenues and future directions
por: Castro, Joana, et al.
Publicado: (2022)

Insulin-regulated aminopeptidase contributes to setting the intensity of FcR-mediated inflammation
por: Bratti, Manuela, et al.
Publicado: (2022)

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
por: Chabot, Sophie, et al.
Publicado: (2011)

Human Perforin Employs Different Avenues to Damage Membranes
por: Praper, Tilen, et al.
Publicado: (2011)

miR-aculous new avenues for cancer immunotherapy
por: Tang, William W., et al.
Publicado: (2022)

TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells
por: Ghamlouch, Hussein, et al.
Publicado: (2014)

Neonatal Immunization: Rationale, Current State, and Future Prospects
por: Whittaker, Elizabeth, et al.
Publicado: (2018)

New Avenues to Design Toxoplasma Vaccines Based on Oocysts and Cysts
por: Arranz-Solís, David, et al.
Publicado: (2022)

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives
por: Kwok, Marwan, et al.
Publicado: (2021)

Editorial: Immune intervention avenues to control fungal infections in immunocompromised individuals
por: Nanjappa, Som G.
Publicado: (2023)

The menopause transition in women living with HIV: current evidence and future avenues of research
por: Tariq, Shema, et al.
Publicado: (2016)

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
por: Rizvi, Ali A., et al.
Publicado: (2021)

Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia
por: Mkaddem, Sanae Ben, et al.
Publicado: (2010)

Osteosarcoma: Lessons Learned and Future Avenues
por: Puri, Ajay, et al.
Publicado: (2013)

Modular Organization of Engulfment Receptors and Proximal Signaling Networks: Avenues to Reprogram Phagocytosis
por: Britt, Emily A., et al.
Publicado: (2021)

Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions
por: Anwar, Imran J., et al.
Publicado: (2022)

MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues
por: Delay, Charlotte, et al.
Publicado: (2011)

Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues
por: He, Da-Long, et al.
Publicado: (2023)

NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
por: Bjorgen, Jacob C., et al.
Publicado: (2023)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

Future avenues of research in particle physics at CERN
por: Hoogland, Walter
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_5ov97gncokjgiil6fe5mlhkn3a